● Recruiting

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Condition: Polycythemia Vera (PV) · Sponsor: PharmaEssentia Japan K.K.

PhasePhase 3

Planned participants67

Who can joinAll sexes, 20 Years to no upper limit

Healthy volunteersNo

About this study

This is a Phase 3 open-label, multicenter, single arm study designed to evaluate the efficacy and safety and tolerability of P1101 patient with PV or ET in long-term.

This description comes directly from the study's public registry record.

Talk to the study team

Hiroaki Kawase · +81-3-6910-5103 · hiroaki_kawase@pharmaessentia.com

Always discuss trial participation with your own doctor first.

Locations (6)

Ehime University Hospital	Toon-shi, Ehime, Japan	Recruiting
Mie University Hospital	Tsu, Mie-ken, Japan	Recruiting
Osaka University Hospital	Suita-shi, Osaka, Japan	Recruiting
Juntendo University Hospital	Bunkyo-ku, Tokyo, Japan	Recruiting
Tokyo Medical University Hospital	Shinjuku-ku, Tokyo, Japan	Recruiting
University of Yamanashi Hospital	Chuo-shi, Yamanashi, Japan	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04655092